Medical Abortion Provided by Nurse-Midwives or Physicians in a High Resource Setting: A Cost-Effectiveness Analysis

被引:22
|
作者
Sjostrom, Susanne [1 ]
Kallner, Helena Kopp [1 ,2 ]
Simeonova, Emilia [3 ]
Madestam, Andreas [4 ]
Gemzell-Danielsson, Kristina [1 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden
[2] Karolinska Inst, Dept Clin Sci, Danderyds Hosp, Dept Obstet & Gynecol, Stockholm, Sweden
[3] Johns Hopkins Univ, Carey Sch Business, Baltimore, MD USA
[4] Stockholm Univ, Dept Econ, Stockholm, Sweden
来源
PLOS ONE | 2016年 / 11卷 / 06期
基金
瑞典研究理事会;
关键词
ACTING REVERSIBLE CONTRACEPTION; UNINTENDED PREGNANCY; UNITED-STATES; POSTABORTION CONTRACEPTION; SAFE ABORTION; CARE; CHOICE; COHORT; TRIAL;
D O I
10.1371/journal.pone.0158645
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective The objective of the present study is to calculate the cost-effectiveness of early medical abortion performed by nurse-midwifes in comparison to physicians in a high resource setting where ultrasound dating is part of the protocol. Non-physician health care professionals have previously been shown to provide medical abortion as effectively and safely as physicians, but the cost-effectiveness of such task shifting remains to be established. Study design A cost effectiveness analysis was conducted based on data from a previously published randomized-controlled equivalence study including 1180 healthy women randomized to the standard procedure, early medical abortion provided by physicians, or the intervention, provision by nurse-midwifes. A 1.6% risk difference for efficacy defined as complete abortion without surgical interventions in favor of midwife provision was established which means that for every 100 procedures, the intervention treatment resulted in 1.6 fewer incomplete abortions needing surgical intervention than the standard treatment. The average direct and indirect costs and the incremental cost-effectiveness ratio (ICER) were calculated. The study was conducted at a university hospital in Stockholm, Sweden. Results The average direct costs per procedure were EUR 45 for the intervention compared to EUR 58.3 for the standard procedure. Both the cost and the efficacy of the intervention were superior to the standard treatment resulting in a negative ICER at EUR -831 based on direct costs and EUR -1769 considering total costs per surgical intervention avoided. Conclusion Early medical abortion provided by nurse-midwives is more cost-effective than provision by physicians. This evidence provides clinicians and decision makers with an important tool that may influence policy and clinical practice and eventually increase numbers of abortion providers and reduce one barrier to women's access to safe abortion.
引用
收藏
页数:9
相关论文
共 44 条
  • [1] Effectiveness and safety of early medication abortion provided in pharmacies by auxiliary nurse-midwives: A non-inferiority study in Nepal
    Rocca, Corinne H.
    Puri, Mahesh
    Shrestha, Prabhakar
    Blum, Maya
    Maharjan, Dev
    Grossman, Daniel
    Regmi, Kiran
    Darney, Philip D.
    Harper, Cynthia C.
    PLOS ONE, 2018, 13 (01):
  • [2] Comparative satisfaction of receiving medical abortion service from nurses and auxiliary nurse-midwives or doctors in Nepal: results of a randomized trial
    Tamang, Anand
    Shah, Iqbal H.
    Shrestha, Pragya
    Warriner, I. K.
    Wang, Duolao
    Thapa, Kusum
    Huong, N. T. My
    Meirik, Olav
    REPRODUCTIVE HEALTH, 2017, 14
  • [3] Utility and cost-effectiveness of screening for hepatocellular carcinoma in a resource-limited setting
    Eltabbakh, Mohamed
    Zaghla, Hassan
    Abdel-Razek, Wael
    Elshinnawy, Hassan
    Ezzat, Sameera
    Gomaa, Asmaa
    Waked, Imam
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 7
  • [4] Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists
    Cantor, Scott B.
    Deshmukh, Ashish A.
    Luca, Nancy Stancic
    Nogueras-Gonzalez, Graciela M.
    Rajan, Tanya
    Prokhorov, Alexander V.
    ADDICTIVE BEHAVIORS, 2015, 45 : 79 - 86
  • [5] Incorporating future unrelated medical costs in cost-effectiveness analysis in China
    Jiang, Shan
    Wang, Yitong
    Zhou, Junwen
    Jiang, Yawen
    Liu, Gordon Guo-En
    Wu, Jing
    BMJ GLOBAL HEALTH, 2021, 6 (10):
  • [6] Cost-effectiveness of prevention and management of diabetic foot ulcer and amputation in a health resource-limited setting
    Wu, Bin
    Wan, Xu
    Ma, Jing
    JOURNAL OF DIABETES, 2018, 10 (04) : 320 - 327
  • [7] Twenty-Week Abortion Bans on Pregnancies With a Congenital Diaphragmatic Hernia A Cost-Effectiveness Analysis
    Bullard, Kimberley A.
    Shaffer, Brian L.
    Greiner, Karen S.
    Skeith, Ashley E.
    Rodriguez, Maria I.
    Caughey, Aaron B.
    OBSTETRICS AND GYNECOLOGY, 2018, 131 (03): : 581 - 590
  • [8] The cost-effectiveness of palivizumab in infants with cystic fibrosis in the Canadian setting: A decision analysis model
    McGirr, Ashleigh A.
    Schwartz, Kevin L.
    Allen, Upton
    Solomon, Melinda
    Sander, Beate
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (03) : 599 - 606
  • [9] Boceprevir for Chronic Genotype 1 Hepatitis C Virus in the Current Health Care Setting in Greece: A Cost-effectiveness Analysis
    Athanasakis, Kostas
    Ferrante, Shannon Allen
    Kyriopoulos, Ilias-Loannis
    Petrakis, Ioannis
    Hill, Mary
    Retsa, Maria-Pagona
    Kyriopoulos, John
    CLINICAL THERAPEUTICS, 2015, 37 (07) : 1529 - 1540
  • [10] Cost-effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person-level data in a Canadian setting
    Thein, Hla-Hla
    Isaranuwatchai, Wanrudee
    Qiao, Yao
    Wong, Kenny
    Sapisochin, Gonzalo
    Chan, Kelvin K. W.
    Yoshida, Eric M.
    Earle, Craig C.
    CANCER MEDICINE, 2017, 6 (09): : 2017 - 2033